P-130A phase I/II Trial of CRISPR-Cas9-mediated PD-1 knockout Epstein-Barr virus cytotoxic lymphocytes (EBV-CTLs) for advanced stage EBV associated malignancies - Trial in progress. (20th June 2018) - Wei, J; Yan, J; Su, S; Shao, J; Zhao, Y; Xu, Q; Yang, Y; Zou, Z; Huang, X; Liu, B